30
Participants
Start Date
October 2, 2023
Primary Completion Date
July 8, 2024
Study Completion Date
July 8, 2024
Topical aminolevulinate (10% ALA gel)
10% ALA gel to the entire face, without occlusion, followed by a prespecified incubation period
Red light illumination
Illumination of red light of narrow spectrum of 635 nm with a light dose of approximately 37 J/cm2
Cleveland Clinic, Dermatology and Plastic Surgery Institute, Case Comprehensive Cancer Center, Cleveland
Collaborators (1)
The Cleveland Clinic
OTHER
Biofrontera Inc.
INDUSTRY
Case Comprehensive Cancer Center
OTHER